Bundle Branch Block and Need for Permanent Pacemaker, a Major Challenge after TAVR

Courtesy of Dr. Carlos Fava.

The development of new valves for TAVR and the increased experienced of operators have significantly decreased paravalvular leak. However, new bundle Branch block (BBB) and the need for permanent pacemaker (PPM) are still relatively high, and their impact and evolution remain controversial.  

Manejo quirúrgico o percutáneo de los leaks mitralesThe study looked at 816 patients, 437 with no conduction disturbances and 247 with BBB, 132 requiring PPM.

 

Mean age was 81, STS was 3.2%, and there were no differences between the groups.

 

At 30 days, there were no differences in mortality.


Read also: TAVR Is Feasible and Offers Good Outcomes in Patients with Cancer.


At 5 years, mortality was higher in the BBB group, followed by the PPM group, compared against patients with no conduction disturbances (48.4% vs. 46.7% vs. 328%, p=0,003). These differences started to show after one year.

 

Rehospitalization for heart failure was higher in patients presenting BBB and PPM, with no differences in hospitalization days between the 3 groups.


Read also: Percutaneous Closure Systems Are Safe in TAVR and Aneurysms.


There was a significant reduction in left ventricular ejection fraction in BBB and PPM patients, compared against patients with no conduction disturbances.

 

Conclusion

The development of BBB and the need for PPM is frequent after TAVR and they are associated to higher mortality risk and higher hospitalization rate due to heart failure.

 

Gentileza del Dr. Carlos Fava.

 

Original title: Mortality and Heart Failure Hospitalization in Patients With Conduction Abnormalities After Transcatheter Aortic Valve Replacement.

Reference: Troels H. Jørgensen, et al. (J Am Coll Cardiol Intv 2019;12:52–61.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...